A new testing kit has been launched in the UAE for detecting COVID-19 antibodies in people.
It will support the efforts of frontline workers and will also help organisations with the return of their employees to the workplace.
The serology test kits can determine whether individuals have been exposed to the virus and have developed antibodies.
However, they are not meant to replace the traditional RT- PCR testing, and will instead complement its efforts.
The Abu Dhabi-based National Reference Laboratory (NRL), part of Mubadala Healthcare’s network, has announced plans to release the kits to the local market.
While acknowledging that Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) testing remains the gold standard for diagnosing COVID-19, NRL experts are highlighting the benefits of their new serology test kits, stating these complementary antibody tests provide useful information for treating the disease and analyzing its spread, as well as having potential implications for human resource planning.
"While anyone can take these tests to determine whether they have been exposed to the virus and have developed antibodies, it does not mean they can ignore precautions, more studies are needed on the protective nature of the antibodies," said Dr. Laila Abdel Wareth, NRL’s Deputy CEO and Chief Scientific Officer.


സോഷ്യൽ മീഡിയ ഉപയോഗിക്കുന്നതിനുള്ള പ്രായ പരിധി 15 ആയി നിശ്ചയിച്ച് യു എ ഇ
UAE sets 15 as minimum age for social media use
ആഗോളതലത്തിൽ സാമ്പത്തിക പ്രകടനത്തിൽ യു എ ഇയ്ക്ക് ഒന്നാം സ്ഥാനം;പ്രശംസിച്ച് ഷെയ്ഖ് മുഹമ്മദ്
H.H. Sheikh Mohammed lauds UAE for topping global list for economic achievements
No injuries after building fire on Dubai's Sheikh Zayed Road contained
'Dubai-it' initiative to embed Dubai’s work philosophy across generations
Dubai Police, RTA discuss measures to reduce heavy vehicle accidents
Dubai Holding's 'Gift It Forward' distributes repurposed items worth AED 22 million
